Herd Immunity in Graphs & Charts. Not a Rosy Picture. Time to Change a Variable

 

Filmed live at the Hive, Atlanta, Georgia, on December 23, 2020.

 

Adult needle fear and fainting are public health threats that could defeat herd immunity. People are dying from COVID-19. Dr. Baxter explains how we must change a variable immediately if we expect to succeed against the disease and achieve herd immunity.

 

This virus has mutated. Mutations are normal and expected. Why does this one matter? This mutation stiffened the spike proteins. The hook itself is stiffer and more likely to attach (greater transmissibility). Think about sea anemone and their “hooks” or cilia. It’s bad for these cilia to stiffen. In the context of COVID, stiffer spikes = greater spread.

 

Greater spread or higher transmissibility increases the death rate. Dr. Baxter talks about that controversial number, the death rate or R-naught/R0. The higher the R0, the higher the percentage of people who need to be vaccinated to achieve herd immunity. 20% say they won’t vaccinate. 17% say they probably won’t vaccinate. 15% will think they’re immune, but won’t be. 18% are children and there’s no vaccine candidate approved yet for kids.

 

If we do something NOW to address needle fear, we could reach 38M more people. How do we address pain, fear, and fainting? Dr. Baxter is a leader in this field and explains. We must address fear, fainting, and pain in the immediate near term to get close to herd immunity. Let’s get ahead of this virus with an EASY, proven solution for needle pain AND fear. #BuzzyHelps

 

Buzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections and the temporary relief of minor injuries (muscle or tendon aches, splinters and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion and muscle tension.

 

Dr. Amy Baxter, MD, bio & more pain relief options here: https://paincarelabs.com/resources/power-over-pain/

 

Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.

 

 

    Back to Blog